PTGEF Financials 07/16/2014 04:29:34 Portage Biot

PTGEF Financials 07/16/2014 04:29:34
Portage Biotech Inc
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011 Apr 01, 2010
Total Revenue 98 - - -
Cost of Revenue - - - -
Gross Profit 98 - - -
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,560 1,599 2,489 2,573
Non-Recurring Items (67) 777 398 247
Other 2 2 3 -
Operating Income (1,397) (2,379) (2,890) (2,820)
Income From Continuing Operations
Add'l Income/Expense Items (50) (93) (996) (722)
Earnings Before Interest and Tax (1,447) (2,472) (3,886) (3,541)
Interest Expense - - - 681
Earnings Before Tax (1,447) (2,472) (3,886) (4,223)
Income Tax - - - -
Minority Interest - - - (352)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,447) (2,472) (3,886) (3,871)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,447) (2,472) (3,886) (3,871)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,447) (2,472) (3,886) (3,871)